# The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome

> **NCT04416620** · NA · COMPLETED · sponsor: **Applied Science Private University** · enrollment: 118 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **OTHER:** The PCOS pharmaceutical care service

## Key facts

- **NCT ID:** NCT04416620
- **Lead sponsor:** Applied Science Private University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-07-30
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04416620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04416620, "The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04416620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*